tirzepatide type 1 diabetes Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m Tirzepatide Leads to Significant Weight

"Six months of consistent use and I'm down 20 pounds

A clinician can help guide proper use, avoid ingredient conflicts, and set realistic expectations based on what current evidence actually supports

Tirzepatide, a newer dual GLP-1 and GIP medication, has demonstrated even greater effectiveness in clinical trials, with weight loss of up to 20%

Understanding the tirzepatide dosage in units and semaglutide dosage in units helps patients and clinicians discuss dosing strategies more precisely

To highlight just a couple, their ASC30 small molecule that offers ultra long-acting potential with monthly dosing options and potentially even quarterly maintenance dosing